Laura Collins

1.2k total citations
30 papers, 618 citations indexed

About

Laura Collins is a scholar working on Molecular Biology, Immunology and Ophthalmology. According to data from OpenAlex, Laura Collins has authored 30 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Immunology and 13 papers in Ophthalmology. Recurrent topics in Laura Collins's work include Ocular Oncology and Treatments (13 papers), Immunotherapy and Immune Responses (12 papers) and Ubiquitin and proteasome pathways (3 papers). Laura Collins is often cited by papers focused on Ocular Oncology and Treatments (13 papers), Immunotherapy and Immune Responses (12 papers) and Ubiquitin and proteasome pathways (3 papers). Laura Collins collaborates with scholars based in United States, Ireland and United Kingdom. Laura Collins's co-authors include Keith D. Rochfort, Philip M. Cummins, Ronan P. Murphy, Linda Troeberg, Christine E. Loscher, Joseph DeCourcey, Brian T. Collins, Shaad E. Abdullah, Alexander N. Shoushtari and Omid Hamid and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Laura Collins

28 papers receiving 609 citations

Peers

Countries citing papers authored by Laura Collins

Since Specialization

Citations

This map shows the geographic impact of Laura Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Collins more than expected).

Fields of papers citing papers by Laura Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Collins. The network helps show where Laura Collins may publish in the future.

Co-authorship network of co-authors of Laura Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Collins. A scholar is included among the top collaborators of Laura Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Collins. Laura Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp 2025 ·European Journal of Cancer ·Volkan Beylergil, Laura Collins, Lawrence H. Schwartz, (unknown), Binsheng Zhao, Stéphane Champiat, Richard D. Carvajal, (unknown), Laurent Dercle	1
2	Use of baseline and serial ctDNA dynamics to predict outcomes in patients treated with first-line tebentafusp, including those who were and were not treated beyond progression. 2024 ·Journal of Clinical Oncology ·Ryan J. Sullivan, Laura Collins, Joseph J. Sacco, Piruntha Thiyagarajah, Paul Nathan, Richard D. Carvajal	1
3	66O Association of a blood T cell fitness gene signature with clinical benefit from ImmTAC bispecific T cell engagers 2024 ·Annals of Oncology ·(unknown), (unknown), Omid Hamid, (unknown), Laura Collins, Marcus O. Butler, (unknown), Jessica C. Hassel, (unknown), (unknown), Paul Nathan, J.M. Piulats Rodriguez, Heather M. Shaw, Diwakar Davar, Chongyang Han, (unknown), (unknown), (unknown), K. Ranade, Tomomi Sato	1
4	Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma 2024 ·Journal for ImmunoTherapy of Cancer ·Joseph J. Sacco, Richard D. Carvajal, Marcus O. Butler, Alexander N. Shoushtari, Jessica C. Hassel, Alexandra P. Ikeguchi, Leonel F. Hernandez‐Aya, Paul Nathan, Omid Hamid, Josep M. Piulats, Matthew J. Rioth, Douglas B. Johnson, Jason J. Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, C. Holland, Takami Sato	13
5	Abstract 1035: Early ctDNA reduction is associated with better overall survival in the Ph 3 trial of tebentafusp in previously untreated metastatic uveal melanoma 2023 ·Cancer Research ·Ryan J. Sullivan, Laura Collins, Manuel Rodrigues, Paul Nathan, Jessica C. Hassel, Reinhard Dummer, John M. Kirkwood, Piotr Rutkowski, Jean‐François Baurain, Marcus O. Butler, Max Schlaak, Sebastian Ochsenreither, Shaad E. Abdullah, Chris Holland, Koustubh Ranade, Alexander N. Shoushtari	1
6	819 Radiomic markers associated with clinical benefit in advanced uveal melanoma patients with radiographic progression on tebentafusp 2021 ·SHILAP Revista de lepidopterología ·Volkan Beylergil, Laura Collins, Lawrence H. Schwartz, (unknown), Binsheng Zhao, Richard D. Carvajal, Shaad E. Abdullah, Laurent Dercle	1
7	Identification of a C3′-nitrile nucleoside analogue inhibitor of pancreatic cancer cell line growth 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Laura Collins, (unknown), (unknown), (unknown), (unknown), Michel Prévost, Mona Nemer, Yvan Guindon	6
8	LRP1 Controls TNF Release via the TIMP-3/ADAM17 Axis in Endotoxin-Activated Macrophages 2019 ·The Journal of Immunology ·Kristin Schubert, Laura Collins, Patricia Green, Hideaki Nagase, Linda Troeberg	17
9	Heparan sulfate as a regulator of inflammation and immunity 2018 ·Journal of Leukocyte Biology ·Laura Collins, Linda Troeberg	94
10	Tumour necrosis factor‐α‐mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin‐6 2015 ·Journal of Neurochemistry ·Keith D. Rochfort, Laura Collins, (unknown), Philip M. Cummins	83
11	A Role for Syntaxin 3 in the Secretion of IL-6 from Dendritic Cells Following Activation of Toll-Like Receptors 2015 ·Frontiers in Immunology ·Laura Collins, Joseph DeCourcey, Keith D. Rochfort, (unknown), Christine E. Loscher	18
12	An Emerging Role for SNARE Proteins in Dendritic Cell Function 2015 ·Frontiers in Immunology ·Laura Collins, Joseph DeCourcey, (unknown), Keith D. Rochfort, Christine E. Loscher	16
13	Shear-Dependent Attenuation of Cellular ROS Levels can Suppress Proinflammatory Cytokine Injury to Human Brain Microvascular Endothelial Barrier Properties 2015 ·Journal of Cerebral Blood Flow & Metabolism ·Keith D. Rochfort, Laura Collins, (unknown), Philip M. Cummins	23
14	Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions 2014 ·PLoS ONE ·Keith D. Rochfort, Laura Collins, Ronan P. Murphy, Philip M. Cummins	209
15	Adult vascular smooth muscle cells in culture express neural stem cell markers typical of resident multipotent vascular stem cells 2014 ·Cell and Tissue Research ·(unknown), Ciarán J. Mooney, (unknown), (unknown), Shaunta Guha, Laura Collins, Christine E. Loscher, D. John Morrow, Eileen M. Redmond, Paul A. Cahill	12
16	Embryonic rat vascular smooth muscle cells revisited - a model for neonatal, neointimal SMC or differentiated vascular stem cells? 2014 ·PubMed ·(unknown), (unknown), Chris Greene, Ciarán J. Mooney, (unknown), Laura Collins, Christine E. Loscher, Shaunta Guha, D. John Morrow, Eileen M. Redmond, Paul A. Cahill	23
17	Surface layer proteins isolated from Clostridium difficile induce clearance responses in macrophages 2014 ·Microbes and Infection ·Laura Collins, Mark Lynch, (unknown), (unknown), Keith D. Rochfort, Mary J. O’Connell, Henry J. Windle, Dermot Kelleher, Christine E. Loscher	22
18	Soluble factors from colonic epithelial cells contribute to gut homeostasis by modulating macrophage phenotype 2014 ·Innate Immunity ·(unknown), Laura Collins, Joseph DeCourcey, (unknown), Christine E. Loscher	6
19	Assessment of Malignancy for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspiration Biopsy Evaluated by Whole-Slide Image Analysis 2013 ·American Journal of Clinical Pathology ·Brian T. Collins, Laura Collins	16
20	Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-κBp50 2013 ·Innate Immunity ·Mary Canavan, (unknown), Nadia Ben Larbi, Jennifer K. Dowling, Laura Collins, Finbarr O’Sullivan, (unknown), C. Murphy, Aoife Quinlan, Gerard M. Moloney, Trevor Darby, John MacSharry, Hiroyuki Kagechika, Paul N. Moynagh, Silvia Melgar, Christine E. Loscher	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact